Clancy Sees Future For Long-Term Comparative Effectiveness Research
This article was originally published in The Gray Sheet
Executive Summary
A leading government proponent of evidence-based medicine is looking beyond stimulus funding that allocates hundreds of millions of dollars to comparative effectiveness research and is working to keep it viable for the long term
You may also be interested in...
Institute Of Medicine Sets Top 100 Comparative Effectiveness Priorities
A June 30 Institute of Medicine 1report to Congress includes dozens of surgical- and device-related topics among a list of 100 recommended priorities for federally-funded comparative effectiveness research
Where’s The Comparative Effectiveness Money Going? Plan Is Due July 30
Questions about how the economic stimulus package's $1.1 billion for comparative effectiveness research will be spent should be answered by July 30, when a report is due to Congress
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.